# China DNA Synthesis Market > China DNA Synthesis Market Research Report By Application (Gene Therapy, Synthetic Biology, Molecular Diagnostics, Vaccine Development), By Product Type (Oligonucleotides, Gene Fragments, Gene Libraries), By End User (Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Clinical Laboratories) and By Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, PCR-Based Synthesis) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 20.04% - **2024:** $ 226.69 Million - **2025:** $ 272.12 Million - **2035:** $ 1,691.02 Million - **Key Players:** Thermo Fisher Scientific (US), Illumina (US), Integrated DNA Technologies (US), Eurofins Genomics (DE), GenScript (CN), Twist Bioscience (US), Bioneer (KR), DNA Script (FR), Synthego (US) **Report ID:** MRFR/MED/50504-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/china-dna-synthesis-market-52262 --- ## Market Summary ## **China DNA Synthesis Market Overview** As per MRFR analysis, the China DNA Synthesis Market Size was estimated at 318 (USD Million) in 2023. The China DNA Synthesis Market Industry is expected to grow from 500(USD Million) in 2024 to 1,500 (USD Million) by 2035. The China DNA Synthesis Market CAGR (growth rate) is expected to be around 10.503% during the forecast period (2025 - 2035) **Key China DNA Synthesis Market Trends Highlighted** China’s DNA synthesis market is witnessing significant trends shaped by advancements in biotechnology and the increasing demand for genetic research. The Chinese government is heavily investing in biotechnology sectors, emphasizing the need for innovation and technology development, particularly in areas related to synthetic biology. This fosters an environment conducive to growth in DNA synthesis technologies, as institutions and companies seek to enhance their capabilities in genetic engineering and genomic research.  As a result, collaborations between academia and industry are becoming more prevalent, enabling the sharing of resources and knowledge, which is crucial in driving research breakthroughs.Moreover, the rising focus on personalized medicine in China presents substantial opportunities for the DNA synthesis market. With the growing emphasis on health and medical advancements, synthetic genes are increasingly used for developing tailored therapies and treatments.  The surge in clinical trials and research activities is also contributing to the growth of this market, as healthcare institutions leverage DNA synthesis for various applications, including drug development and diagnostics. A noticeable trend in recent times is the increasing adoption of automation and artificial intelligence in DNA synthesis processes. This shift is driving efficiency and accuracy, leading to a reduction in the cost and time associated with genetic research and applications. Furthermore, China's commitment to fostering domestic biotechnology firms while restricting reliance on foreign entities enhances the competitive landscape within the local DNA synthesis market. As these trends continue to evolve, the market is positioned for sustained growth and innovation, ensuring China remains a key player within the global biotechnology arena. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **China DNA Synthesis Market Drivers** **Growing Demand for Genomic Research** One major factor fueling the expansion of the China DNA Synthesis Market Industry is the rising need for genomic research. The National Medium- and Long-Term Program for Science and Technology Development (2006-2020), which provided significant money for biotechnology research, is proof that the Chinese government has been actively supporting biotechnology programs. In 2021, China spent over 2.4 percent of its GDP on research & development, which amounted to a substantial investment of almost USD 500 billion.  This commitment helps improve the fields of healthcare, agriculture, and the environment by providing substantial funding for genomic and synthetic biology research. The market is expected to increase from 2025 to 2035 due in part to the growing need to produce agricultural and customized health solutions, which is fueled by organizations such as the Chinese Academy of Sciences spearheading several genomic initiatives. The need for DNA synthesis services, which are essential for biological investigations and applications, is driven by the commensurate rise in research activity. **Increase in Genetic Disorders and Cancer Cases** The rise in genetic disorders and cancer cases in China reinforces the growth of the China DNA Synthesis Market Industry. Recent statistics from the National Health Commission indicate that the incidence of cancer in China has increased significantly, with diagnosed cancer cases exceeding 4.57 million in 2020, demonstrating a staggering rise in public health challenges. This upward trend necessitates advanced genetic analysis and therapies that often rely on DNA synthesis for effective diagnostic and treatment options. As healthcare systems adapt to manage this increase, the demand for customized and precise therapeutic solutions is becoming imperative, thereby fueling the demand for DNA synthesis technologies within the market. The ongoing investment in oncology and genetic healthcare initiatives supports the market's forecasted growth. **Advancements in Biotechnology and Synthetic Biology** Rapid advancements in biotechnology and synthetic biology are acting as key drivers for the growth of the China DNA Synthesis Market Industry. Continued innovations in DNA synthesis technologies such as the development of high-throughput sequencing and CRISPR-Cas9 gene editingare significantly enhancing the capabilities of research institutions and biotechnology firms across China. The China National GeneBank, for instance, focuses on integrating genetic resources and technology development, which plays a pivotal role in advancing biological discoveries. As global collaborations in synthetic biology research intensify, Chinese firms are increasingly participating in important projects, enhancing their capacity to develop novel therapeutics, biofuels, and agricultural improvements. Such advancements not only escalate the need for sophisticated DNA synthesis technologies but also suggest a promising landscape for market expansion moving forward. **China DNA Synthesis Market Segment Insights** **DNA Synthesis Market Application Insights** The Application segment of the China DNA Synthesis Market is experiencing noteworthy growth driven by advancements in various fields such as Gene Therapy, Synthetic Biology, Molecular Diagnostics, and Vaccine Development. In the context of Gene Therapy, the significant advancements in genetic modification techniques are transforming treatment protocols, allowing for targeted therapies aimed at curing genetic disorders.  Meanwhile, Synthetic Biology is revolutionizing the design and engineering of biomolecules and organisms, leading to innovations in pharmaceuticals, industrial biotechnology, and environmental sustainability, thereby enhancing China's position as a global leader in biotechnology.  Molecular Diagnostics is another critical area within the market, as the demand for precise and rapid diagnostic solutions continues to increase, particularly in light of recent global health challenges. The focus on early disease detection and personalized medicine has driven growth in this sector. Vaccine Development also plays a pivotal role, showcasing China's robust capabilities in rapid vaccine production and response to emerging health threats, notably highlighted during the COVID-19 pandemic.  The ongoing research initiatives and governmental support further strengthen this domain, positioning China at the forefront of vaccine innovation on an international scale.Each of these areas not only represents a substantial share of the market but also reflects the collaborative efforts of academic institutions, government policies, and private sector investments in biotechnology.  The synergy between these applications fosters a dynamic environment where innovative solutions can emerge, addressing both health and environmental challenges. With the increasing focus on genetic research and biotechnology in the national agenda, China's DNA Synthesis Market is set to play a transformative role in advancing scientific knowledge and application toward a more sustainable and health-conscious future. This evolving landscape suggests an optimistic outlook for the various Applications within the China DNA Synthesis Market as they align with wider global trends and local priorities. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **DNA Synthesis Market Product Type Insights** The China DNA Synthesis Market is characterized by several key product types, notably Oligonucleotides, Gene Fragments, and Gene Libraries, each playing a vital role in the biotechnology landscape. Oligonucleotides are extensively used in Research and Development for applications such as PCR, sequencing, and gene editing, showcasing their significance in driving innovation in synthetic biology. Gene Fragments enable researchers to design and construct synthetic genes, facilitating advancements in areas like personalized medicine and crop engineering, thereby supporting China's push toward biotechnology self-reliance as outlined in national policies. Gene Libraries provide a diverse collection of genetic materials that are crucial for exploring novel functions and pathways in biological research. The availability of varied genetic resources aids in enhancing productivity and efficiency in drug discovery and development. The increasing investments in biotechnology in China, along with a growing focus on genomics, enhance the importance of these product types, contributing to the broader China DNA Synthesis Market data and statistics. Factors such as a surge in demand for synthetic genes in the pharmaceutical and agricultural sectors are expected to further bolster the market growth for these prominent segments within the market landscape. **DNA Synthesis Market End User Insights** The End User segment of the China DNA Synthesis Market plays a vital role in shaping the industry landscape, encompassing Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories. Academic Research Institutions are crucial for advancing genetic studies and driving innovation in DNA synthesis technologies, leveraging vast funding from various government and private sectors. Pharmaceutical Companies utilize DNA synthesis for drug discovery and development, thereby playing a significant role in addressing public health challenges in China.Meanwhile, Biotechnology Companies are focusing on harnessing synthetic biology for therapeutic applications, highlighting the growing intersection of technology and biology in driving market growth.  Clinical Laboratories increasingly rely on DNA synthesis to enhance diagnostic testing and personalized medicine approaches. As research funding in China continues to grow alongside the demand for innovative healthcare solutions, the End User segment is poised for significant expansion, fostering advancements in genetic research and therapeutic applications, which ultimately contribute to the overall China DNA Synthesis Market dynamics.The ongoing investments in genomics and biotechnology depicted in government agendas underline the importance and relevance of this segment within the broader industry. **DNA Synthesis Market Technology Insights** The Technology segment of the China DNA Synthesis Market showcases several innovative methodologies driving the industry forward. Solid-Phase Synthesis is a cornerstone technique well-regarded for its efficiency and precision in generating DNA sequences, making it particularly crucial for applications in genomics and synthetic biology. Meanwhile, Liquid-Phase Synthesis offers flexibility and scalability, accommodating a wide range of synthesis demands, which is vital as the biotech industry in China continues to expand. PCR-Based Synthesis stands out for its capability to amplify specific DNA sequences, supporting various research and clinical applications, and is essential in the landscape of molecular biology. The market is poised for significant growth, with advancements in these technologies contributing to the burgeoning demand for customized and high-throughput DNA synthesis services. The ongoing trend of increased investment in Research and Development within China further propels these methodologies, enabling innovation and adaptations that align with international standards. As the biotechnology sector evolves, understanding the dynamics of these synthesis technologies will be pivotal in addressing the unique demands of the China DNA Synthesis Market. **China DNA Synthesis Market Key Players and Competitive Insights** The China DNA Synthesis Market has shown significant growth over recent years, fueled by advancements in biotechnology and increasing research activity in genomics and synthetic biology. This market is characterized by fierce competition as numerous companies strive to dominate the landscape, capitalizing on the growing demand for synthetic DNA in various applications, such as drug development, agriculture, and diagnostics. The competition is driven by technological innovations, pricing strategies, and the ability to offer customized solutions that cater to a broad range of customer needs. Market participants are not only focused on expanding their product portfolios but also on enhancing their operational efficiencies and reaching new customer segments.  Therefore, understanding the competitive dynamics within this market is critical for stakeholders aiming to achieve sustainable growth and maintain a competitive edge.Thermo Fisher Scientific holds a robust position in the China DNA Synthesis Market due to its extensive range of products and services tailored for genetic research and applications. The company is recognized for its state-of-the-art technology, which facilitates high-throughput DNA synthesis and analysis. Additionally, Thermo Fisher Scientific benefits from a wide distribution network in China, enabling quick and efficient delivery of its products to various research institutions and laboratories across the country.  The company’s strength lies in its commitment to innovation, investing heavily in research and development to introduce cutting-edge solutions that meet the evolving needs of its customers in the rapidly advancing field of genomics. This focus, coupled with strategic partnerships and collaborations with local research entities, has significantly bolstered its market presence in China.Molecular Devices has established a notable presence in the China DNA Synthesis Market, recognized for its innovative technology and comprehensive product offerings that encompass a range of instrumentation and software solutions used in life sciences and drug discovery.  The company is particularly known for its specialized systems that improve the efficiency and accuracy of DNA synthesis processes. In recent years, Molecular Devices has expanded its capabilities through strategic mergers and acquisitions, allowing it to integrate advanced technologies and broaden its market reach in China. This strategy has enhanced its operational proficiency and product range, making it a significant player in the region.  The company’s strengths also include a strong customer support framework, which provides users with essential assistance and training, thereby enhancing customer satisfaction and loyalty towards their products and services. **Key Companies in the China DNA Synthesis Market Include** **China DNA Synthesis Market Industry Developments** The China DNA Synthesis Market has seen significant advancements and developments in recent months, underscored by a growing demand for synthetic DNA in research and therapeutic applications. Companies such as Thermo Fisher Scientific and GenScript are expanding their presence through collaborations and partnerships aimed at enhancing their product offerings within the region. In June 2023, Synthego announced plans to increase its operational capacity in China, tapping into the region's burgeoning biotechnology sector. The market is experiencing notable growth, with significant investments observed from firms like Twist Bioscience and Integrated DNA Technologies, aiming to bolster their market share in China.  Additionally, in August 2023, OriGene Technologies reported a strategic merger with a local biotech firm to enhance its research capabilities, reflecting the increasing trend of consolidation within the industry. Companies are focusing on cutting-edge technologies, with molecular diagnostic applications driving demand. Furthermore, the Chinese government has been supportive, implementing policies that stimulate research and innovation in biotechnology, making the country an attractive hub for both domestic and international players. These factors are reshaping the landscape of the DNA synthesis market in China, fostering a dynamic environment for growth and innovation in the sector. **China DNA Synthesis Market Segmentation Insights** ## Market Drivers ### Growing Academic Research The dna synthesis market is significantly influenced by the expanding academic research sector in China. Universities and research institutions are increasingly engaging in genetic research, which necessitates advanced dna synthesis technologies. In 2025, it is estimated that research funding in the life sciences will exceed $5 billion, with a substantial portion allocated to dna synthesis applications. This trend indicates a robust demand for high-quality synthetic dna, as researchers seek to explore genetic modifications and develop novel therapies. Consequently, the dna synthesis market is poised to thrive, driven by the need for innovative solutions that support scientific discovery and technological advancement. ### Rising Biotech Investments The dna synthesis market in China is experiencing a surge in investments from biotechnology firms. This influx of capital is primarily driven by the increasing focus on research and development in genetic engineering and synthetic biology. In 2025, investments in biotech are projected to reach approximately $10 billion, reflecting a growth rate of around 15% annually. This financial support is crucial for advancing technologies related to dna synthesis, enabling companies to enhance their capabilities and expand their product offerings. As a result, the dna synthesis market is likely to benefit from improved infrastructure and innovative solutions, fostering a competitive landscape that attracts further investment. ### Increased Focus on Genomic Research The dna synthesis market is benefiting from a heightened focus on genomic Market Research Future. With the government prioritizing genomics as a key area for scientific advancement, funding for genomic projects is on the rise. In 2025, it is anticipated that genomic research funding will surpass $3 billion, fostering innovation in dna synthesis technologies. This emphasis on genomics is likely to drive demand for synthetic dna, as researchers require precise and reliable synthesis methods for their studies. As a result, the dna synthesis market is expected to expand, supported by the growing need for advanced genomic tools and resources. ### Emerging Synthetic Biology Applications The emergence of synthetic biology applications is reshaping the dna synthesis market in China. Industries such as agriculture, pharmaceuticals, and environmental science are increasingly adopting synthetic biology techniques to address complex challenges. For instance, the agricultural sector is leveraging dna synthesis to develop genetically modified crops that enhance yield and resistance to pests. This trend is expected to propel the market, with projections indicating a growth rate of 20% in synthetic biology applications by 2027. As these applications proliferate, the dna synthesis market will likely see heightened demand for customized dna solutions tailored to specific industry needs. ### Collaborations Between Industry and Academia Collaborations between industry and academia are playing a pivotal role in the evolution of the dna synthesis market in China. Partnerships between biotech companies and research institutions facilitate knowledge exchange and accelerate the development of new technologies. These collaborations often lead to innovative projects that require advanced dna synthesis capabilities. In 2025, it is projected that such partnerships will increase by 30%, further integrating academic research with commercial applications. This synergy is likely to enhance the dna synthesis market, as it fosters an environment conducive to innovation and the rapid translation of research findings into practical solutions. ## Future Outlook The [DNA synthesis Market](https://www.marketresearchfuture.com/reports/dna-synthesis-market-20306) in China is projected to grow at a 20.04% CAGR from 2025 to 2035, driven by advancements in biotechnology, increased R&D investments, and rising demand for personalized medicine. **New opportunities:** - Development of automated DNA synthesis platforms for rapid prototyping. - Expansion of custom oligonucleotide services targeting niche markets. - Partnerships with biotech firms for integrated genomic solutions. By 2035, the DNA synthesis market is expected to achieve substantial growth, positioning itself as a leader in biotechnological advancements. ## Segment Insights ### By Application: Gene Therapy (Largest) vs. Synthetic Biology (Fastest-Growing) In the China dna synthesis market, Gene Therapy captures the largest share, driven by significant advancements in genetic modifications aimed at treating various hereditary conditions. Synthetic Biology follows closely, with a rapidly growing presence thanks to innovative applications in pharmaceuticals and environmental solutions. Recent trends indicate that while Gene Therapy remains dominant, the emergence of Synthetic Biology is fueled by increased investments in research and development. Additionally, the ongoing demand for personalized medicine and sustainable solutions contributes to the robustness of this segment, positioning it as a key player in the future of biotechnology. Gene Therapy: Dominant vs. Synthetic Biology: Emerging Gene Therapy is characterized by its potential to provide long-lasting solutions for genetic disorders, harnessing cutting-edge techniques such as CRISPR and viral vectors for targeted treatments. This segment holds a critical position in healthcare advancements as more patients seek customized therapies. In contrast, Synthetic Biology is emerging as a transformative force, enabling the design and construction of new biological parts and systems. This field is not only pivotal for novel drug development but also for sustainable biomanufacturing processes. The synergistic development across these segments showcases the dynamic landscape of the China dna synthesis market. ### By Product Type: Oligonucleotides (Largest) vs. Gene Fragments (Fastest-Growing) In the product type segmentation of the China dna synthesis market, oligonucleotides hold the largest market share, driven by their essential role in various applications such as diagnostics, therapeutics, and research. Gene fragments also present significant market potential but occupy a smaller share compared to oligonucleotides. Meanwhile, gene libraries, while important, are emerging as a niche segment with unique applications in genomic studies and synthetic biology. The growth trends in this segment are largely influenced by advancements in genomic research and increased funding in biotechnology. The demand for personalized medicine and targeted therapies is propelling the growth of oligonucleotides. Meanwhile, gene fragments are gaining traction due to their role in synthetic biology, which is recognized for its innovative approaches in genetic engineering and novel therapeutic discovery. Oligonucleotides (Dominant) vs. Gene Fragments (Emerging) Oligonucleotides are the dominant force in the product type segment, prized for their versatility and applicability across a range of fields, including molecular diagnostics and therapeutic developments. Their established presence and a variety of uses solidify their position as the go-to choice for researchers and clinicians. In contrast, gene fragments are an emerging player, finding their niche within areas such as synthetic biology and genetic engineering, where their customized characteristics can be employed for specific experimental needs. This shift towards innovation in genetic manipulation is fostering a growing demand for gene fragments, although they currently do not match the widespread use of oligonucleotides. ### By End User: Academic Research Institutions (Largest) vs. Pharmaceutical Companies (Fastest-Growing) In the China dna synthesis market, Academic Research Institutions hold the largest market share, driven by extensive research activities and funding from government initiatives. Pharmaceutical Companies, meanwhile, wield significant influence but are observing rapid growth due to the increasing demand for personalized medicine and therapeutic advancements that incorporate synthetic DNA technologies. The growth trend in this segment is primarily propelled by the rising number of research collaborations between Academic Research Institutions and industry players, as well as substantial investments in biotech research by Pharmaceutical Companies. Additionally, the ongoing advancements in dna synthesis technologies have enabled these institutions to expedite research timelines, thereby enhancing overall productivity and innovation in drug development processes. Academic Research Institutions (Dominant) vs. Pharmaceutical Companies (Emerging) Academic Research Institutions play a dominant role in the China dna synthesis market, leveraging cutting-edge research to drive innovations and facilitate breakthroughs in genetics and molecular biology. They benefit from collaboration with government bodies and global research networks, which provide resources and funding. On the other hand, Pharmaceutical Companies are emerging as key players by rapidly adopting dna synthesis technologies to enhance drug development and personalized medicine initiatives. Their investments in research and development are accelerating the commercialization of synthetic DNA applications, thereby positioning them for substantial growth. This dynamic creates a robust ecosystem where Academic Research Institutions and Pharmaceutical Companies synergize to foster scientific advancements. ### By Technology: Solid-Phase Synthesis (Largest) vs. PCR-Based Synthesis (Fastest-Growing) In the China dna synthesis market, the Solid-Phase Synthesis method holds a significant portion of the market share, characterized by its efficiency in producing high-quality oligonucleotides. This method has established itself as the preferred choice among researchers and commercial entities due to its reliability and superior performance. Meanwhile, the Liquid-Phase Synthesis method, while smaller in share, offers unique advantages in specific applications, contributing to a diverse technological landscape. The growth trends within this segment are primarily driven by advancements in sequencing technologies and increasing investments in biotechnology initiatives. PCR-Based Synthesis is emerging rapidly, fueled by its ability to facilitate quick and efficient amplification of DNA samples. The focus on personalized medicine and genetically tailored treatments in the China dna synthesis market is expected to further accelerate growth, paving the way for innovative applications and methodologies. Technology: Solid-Phase Synthesis (Dominant) vs. PCR-Based Synthesis (Emerging) Solid-Phase Synthesis stands out as the dominant technology in the segment, favored for its robustness and high purity yields in oligonucleotide synthesis. This method benefits from extensive research and development, allowing it to deliver high-fidelity results that are essential for various genomic studies. On the other hand, PCR-Based Synthesis represents an emerging frontier in the market, gaining traction for its speed and adaptability in processing DNA, particularly in applications like diagnostics and synthetic biology. As the demand for rapid, precise, and cost-effective solutions grows, both technologies are poised to play crucial roles in the evolution of the China dna synthesis market. ## Competitive Benchmarking The dna synthesis market in China is characterized by a dynamic competitive landscape, driven by rapid technological advancements and increasing demand for synthetic biology applications. Key players such as Thermo Fisher Scientific (US), GenScript (CN), and Twist Bioscience (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Thermo Fisher Scientific (US) focuses on innovation and expanding its product portfolio, while GenScript (CN) emphasizes local manufacturing capabilities to cater to the growing domestic demand. Twist Bioscience (US) leverages its proprietary silicon-based DNA synthesis technology to differentiate itself in a crowded market, collectively shaping a competitive environment that is increasingly reliant on technological prowess and operational efficiency.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance responsiveness to market needs. The market structure appears moderately fragmented, with several players vying for market share, yet the influence of major companies is substantial. This competitive structure fosters an environment where innovation and strategic partnerships are critical for success, as companies seek to leverage each other's strengths to navigate the complexities of the market. In October Thermo Fisher Scientific (US) announced a strategic partnership with a leading Chinese biotech firm to co-develop next-generation sequencing technologies. This collaboration is poised to enhance Thermo Fisher's capabilities in the region, allowing for tailored solutions that meet local market demands. The strategic importance of this partnership lies in its potential to accelerate product development cycles and improve market penetration in China, a region with burgeoning demand for advanced genomic solutions. In September GenScript (CN) launched a new line of custom DNA synthesis services aimed at academic and industrial researchers. This initiative is significant as it not only expands GenScript's service offerings but also positions the company as a key player in supporting the growing synthetic biology research community in China. By enhancing its service portfolio, GenScript is likely to capture a larger share of the market, particularly among researchers seeking high-quality, customized solutions. In August Twist Bioscience (US) unveiled a new platform for high-throughput DNA synthesis, which is expected to revolutionize the way synthetic DNA is produced. This technological advancement is crucial as it addresses the increasing demand for rapid and cost-effective DNA synthesis solutions. The introduction of this platform may provide Twist with a competitive edge, enabling it to meet the needs of a diverse clientele while reinforcing its position as an innovator in the market. As of November current trends in the dna synthesis market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into production processes. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, supply chain reliability, and the ability to deliver customized solutions. This shift underscores the importance of agility and responsiveness in a rapidly changing market. ## Recent News & Developments The China DNA Synthesis Market has seen significant advancements and developments in recent months, underscored by a growing demand for synthetic DNA in research and therapeutic applications. Companies such as Thermo Fisher Scientific and GenScript are expanding their presence through collaborations and partnerships aimed at enhancing their product offerings within the region. In June 2023, Synthego announced plans to increase its operational capacity in China, tapping into the region's burgeoning biotechnology sector. The market is experiencing notable growth, with significant investments observed from firms like Twist Bioscience and Integrated DNA Technologies, aiming to bolster their market share in China.  Additionally, in August 2023, OriGene Technologies reported a strategic merger with a local biotech firm to enhance its research capabilities, reflecting the increasing trend of consolidation within the industry. Companies are focusing on cutting-edge technologies, with molecular diagnostic applications driving demand. Furthermore, the Chinese government has been supportive, implementing policies that stimulate research and innovation in biotechnology, making the country an attractive hub for both domestic and international players. These factors are reshaping the landscape of the DNA synthesis market in China, fostering a dynamic environment for growth and innovation in the sector. ## Report Scope | MARKET SIZE 2024 | 226.69(USD Million) | | --- | --- | | MARKET SIZE 2025 | 272.12(USD Million) | | MARKET SIZE 2035 | 1691.02(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 20.04% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Thermo Fisher Scientific (US), Illumina (US), Integrated DNA Technologies (US), Eurofins Genomics (DE), GenScript (CN), Twist Bioscience (US), Bioneer (KR), DNA Script (FR), Synthego (US) | | Segments Covered | Application, Product Type, End User, Technology | | Key Market Opportunities | Advancements in personalized medicine drive demand for tailored solutions in the dna synthesis market. | | Key Market Dynamics | Rapid advancements in technology drive innovation and competition in the DNA synthesis market. | | Countries Covered | China | ## Frequently Asked Questions **Q: What is the projected market valuation for the China DNA synthesis market by 2035?** A: The projected market valuation for the China DNA synthesis market is $1691.02 Million by 2035. **Q: What was the overall market valuation for the China DNA synthesis market in 2024?** A: The overall market valuation for the China DNA synthesis market was $226.69 Million in 2024. **Q: What is the expected CAGR for the China DNA synthesis market during the forecast period 2025 - 2035?** A: The expected CAGR for the China DNA synthesis market during the forecast period 2025 - 2035 is 20.04%. **Q: Which application segment had the highest valuation in 2024 within the China DNA synthesis market?** A: The Molecular Diagnostics application segment had the highest valuation at $600.0 Million in 2024. **Q: What are the key players in the China DNA synthesis market?** A: Key players in the China DNA synthesis market include Thermo Fisher Scientific, Illumina, Integrated DNA Technologies, Eurofins Genomics, GenScript, Twist Bioscience, Bioneer, DNA Script, and Synthego. **Q: Which product type segment is projected to grow the most by 2035?** A: The Oligonucleotides product type segment is projected to grow significantly, reaching $680.0 Million by 2035. **Q: What was the valuation of the Gene Therapy application segment in 2024?** A: The Gene Therapy application segment was valued at $250.0 Million in 2024. **Q: Which end user segment had the highest valuation in 2024?** A: The Pharmaceutical Companies end user segment had the highest valuation at $525.0 Million in 2024. **Q: What technology segment is expected to see the most growth by 2035?** A: The PCR-Based Synthesis technology segment is expected to see substantial growth, reaching $901.02 Million by 2035. **Q: How does the valuation of the Vaccine Development application segment compare to others in 2024?** A: The Vaccine Development application segment was valued at $441.02 Million in 2024, indicating strong performance compared to other segments. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-dna-synthesis-market-52262*